Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 9/20 | 0.83 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | TDO2 | P48775 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalazine SCHEMBL27500832 | 0.93 | EGFR (0.71) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinazoline SCHEMBL29356169 | 0.91 | EGFR (1.00) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinazoline SCHEMBL29490398 | 0.91 | EGFR (1.00) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinazoline SCHEMBL22833783 | 0.91 | EGFR (1.00) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinazoline SCHEMBL5920 | 0.91 | EGFR (1.00) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinoline SCHEMBL156755 | 0.90 | EGFR (0.80) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| SCHEMBL3196932 | 0.89 | EGFR (0.95) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinazoline SCHEMBL1119374 | 0.89 | EGFR (0.95) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinazoline SCHEMBL4487630 | 0.89 | EGFR (0.95) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB | |
| Quinazoline SCHEMBL21055790 | 0.89 | EGFR (0.95) | EGFRPIK3CDPIK3CAALDH1A1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101932317-A | Stable pharmaceutical composition | ASAHI KASEI PHARMA CORP | 2010-12-29 | — | — | CN | claimed |
| CN-1418192-A | Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof | AVENTIS PHARMA SA (FR) | 2003-05-14 | — | — | CN | claimed |
| CN-1411440-A | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and process for preparing same | AVENTIS PHARMA SA (FR) | 2003-04-16 | — | — | CN | claimed |
| CN-117430641-A | Organic electroluminescent material and device | 环球展览公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-115298846-A | Organic electroluminescent element | 日铁化学材料株式会社 | 2022-11-04 | — | — | CN | disclosed |
| US-11302872-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-12 | — | — | US | disclosed |
| US-9698411-B2 | Electrode for battery and production method thereof, nonaqueous electrolyte battery, battery pack, and active material | KABUSHIKI KAISHA TOSHIBA (JP) | 2017-07-04 | — | — | US | disclosed |
| EP-2677574-B1 | BATTERY ELECTRODE AND MANUFACTURING METHOD THEREOF, NON-AQUEOUS ELECTROLYTE BATTERY, BATTERY PACK, AND ACTIVE MATERIAL | TOSHIBA KK (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-20170069848-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-09 | — | — | US | disclosed |
| CN-103210531-B | Battery electrode and method for producing same, nonaqueous electrolyte battery, battery pack, and active material | TOSHIBA CORP. (JP) | 2016-06-01 | — | — | CN | disclosed |
| CN-102403509-B | Battery electrode, the method for preparing described battery electrode, nonaqueous electrolyte battery, battery pack and active material | TOSHIBA CORP (JP) | 2016-05-04 | — | — | CN | disclosed |
| CN-1660720-A | Method for producing molecular compound | NIPPON SODA CO (JP) | 2005-08-31 | — | — | CN | disclosed |
| CN-1205153-C | Method for producing molecular compound | NIPPON SODA CO (JP) | 2005-06-08 | — | — | CN | disclosed |
| WO-2005009994-A1 | NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS | PFIZER LIMITED (GB) | 2005-02-03 | — | — | WO | disclosed |
| CN-1187325-C | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | AVENTIS PHARMA SA (FR) | 2005-02-02 | — | — | CN | disclosed |
| CN-1479704-A | Method for producing molecular compound | �ձ�������ʽ���� | 2004-03-03 | — | — | CN | disclosed |
| CN-1411440-A | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and process for preparing same | AVENTIS PHARMA SA (FR) | 2003-04-16 | — | — | CN | disclosed |
| CN-1399733-A | Salt-like structured silicates as charge control agents | CLARIANT GMBH (DE) | 2003-02-26 | — | — | CN | disclosed |
| CN-1067419-C | Reactive dyestuffs their preparation and their use | BAYER AG (DE) | 2001-06-20 | — | — | CN | disclosed |
| CN-1106845-A | Reactive dyestuffs their preparation and their use | BAYER AG (DE) | 1995-08-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170069848-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | EML4, IKZF2, BPTF | EGFR 1000/4885PIK3CD 4172/4885PIK3CA 4481/4885 |
| US-11302872-B2 | Organic electroluminescent materials and devices | EML4, IKZF2, BPTF | EGFR 1000/4885PIK3CD 4172/4885PIK3CA 4481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.